First Affiliated Hospital of Zhejiang University — Biomedical Watch V2

Traitements4programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

4

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseThe goal of this observational study is to valuate the sensitivity and specificity of different blood biomarkers for monitoring and assessing Aβ-PET-confirmed mitigation of amyloid pathology by lencanumab treatment in subjects treated with lencanumab.	Alzheimer	À vérifier	À vérifier	China	À vérifier
Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T CellsThis is a single-arm, open-label, dose escalation, phase I study, aiming to evaluate the safety and efficacy of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific Chimeric Antigen Receptor (CAR) T-cells in patient with relapsed or refractory diffuse B cell lymphoma.	SEP	Phase 1	Immunomodulation	China	À vérifier
An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseThe goal of this observational study is to valuate the sensitivity and specificity of different blood biomarkers for monitoring and assessing Aβ-PET-confirmed mitigation of amyloid pathology by lencanumab treatment in subjects treated with lencanumab.	Alzheimer	À vérifier	À vérifier	China	À vérifier
Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T CellsThis is a single-arm, open-label, dose escalation, phase I study, aiming to evaluate the safety and efficacy of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific Chimeric Antigen Receptor (CAR) T-cells in patient with relapsed or refractory diffuse B cell lymphoma.	SEP	Phase 1	Immunomodulation	China	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T Cells	SEP	Phase 1	NCT04486872	An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of Differentiation Antigen 19/20(CD19/CD20) Dual Specific CAR-T Cells Injection	UNKNOWN
Prizloncabtagene Autoleucel	SEP	Phase 1	NCT04693676	A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma	UNKNOWN
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease	Alzheimer	À vérifier	NCT07153848	An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.